4-Bromo-5-phenyl-3-trifluoromethylpyrazole, 97.0%, 5g

N,N-Bis[2-(p-tolylsulfonyloxy)ethyl]-p-toluenesulfonamide>98.0%(HPLC)(N)25g

1,3-Di-tert-butyl-1,3,2-diazaphospholidine 2-Oxide>95.0%(GC)1g

5-bromo-3-methyl-2-(4H-1,2,4-triazol-4-yl)pyridine, 95.0%, 10g

Fmoc-Tyr-OtBu, 97%, 10g

(4-(5-Fluoropyridin-2-yl)phenyl)methanol, 95+%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-methoxy-1H-indol-3-yl)propanoic acid, 97%, 1g

2-Bromo-1-(ethoxymethyl)-4-nitro-1H-imidazole, 97%, 25g

(R)-Methyl 2-(((benzyloxy)carbonyl)amino)but-3-enoate, 95.0%, 250mg

(6-FLUOROIMIDAZO[1,2-A]PYRIDIN-3-YL)METHANAMINE, 95.0%, 250mg

2-Methoxy-N-[3-[(3-methylbenzoyl)amino]phenyl]benzamide, 98%, 50mg

4-Aminomethylbenzylalcohol, 95.0%, 1g

1,1'-Diethyl-2,2'-cyanine Iodide>98.0%(HPLC)1g